Anthrax dispute suggests Bioshield woes
• AP5 years after anthrax attacks left 5 dead, sickened 17 and panicked the country, the nearly $1 billion contract awarded by the U.S. to a tiny San Francisco Bay Area biotechnology company is plagued with misfortune and delays.
